v3.23.3
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Revenue $ 6,136 $ 2,763 $ 15,936 $ 7,324
Costs and expenses:        
Cost of revenue (excluding depreciation and amortization) 2,008 733 4,945 2,043
Research and development 24,599 13,292 60,701 30,282
Sales and marketing 5,047 1,969 11,289 5,971
General and administrative 13,927 10,149 35,438 26,901
Depreciation and amortization 2,749 1,531 6,869 4,248
Total operating costs and expenses 48,330 27,674 119,242 69,445
Loss from operations (42,194) (24,911) (103,306) (62,121)
Change in fair value of warrant liabilities (7,640) (1,151) (26,787) 28,358
Interest income, net 5,007 2,059 14,115 3,926
Other income (expense), net 55 20 150 (27)
Loss before benefit for income taxes (44,772) (23,983) (115,828) (29,864)
Income tax expense (39) 0 (39) 0
Net loss $ (44,811) $ (23,983) $ (115,867) $ (29,864)
Net loss per share attributable to common stockholders—basic $ (0.22) $ (0.12) $ (0.57) $ (0.15)
Weighted average shares used in computing net loss per share attributable to common stockholders—basic 203,390,383 198,301,240 201,656,916 197,255,965
Net loss per share attributable to common stockholders—diluted $ (0.22) $ (0.12) $ (0.57) $ (0.15)
Weighted average shares used in computing net loss per share attributable to common stockholders—diluted 203,390,383 198,301,240 201,656,916 197,255,965